Information for healthcare professionals on obesity including guidelines, protocols and evidence on the use of VLCDs.
- Clinical Resources
Supporting weight management following GLP-1 de-prescription
One challenge that arises after the completion of any weight loss therapy is weight regain. OPTIFAST VLCD products can be beneficial to help individuals maintain nutritional balance and reduce overall caloric intake to support continued weight management.
Resources for Obesity
Obesity
- Scientific Publications
Clinical Paper Summary: Bacus et al, 2024. Retrospective review of seven patients with obesity simultaneously treated with a combination of a glucagon-like peptide-1 receptor agonist and a meal replacement product
Obesity
- Scientific Publications
Jones et al, 2024. Real world evidence on the characteristics of regular and intermittent users of a very‐low calorie diet program and associations with measures of program success, health, and quality of life.
